Home

Insights

PE

Amrutanjan Health Care Ltd P/E Ratio

Amrutanjan Health Care Ltd P/E Ratio

download
stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

3.3 K

stocks traded

Last Updated time: 14 Jul 9.00 AM

Image

Amrutanjan Health Care Ltd

NSE: AMRUTANJAN

PE

48.3

Last updated : 14 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Amrutanjan Health Care Ltd is 48.3 as of 14 Jul 9.00 AM .a1#The P/E Ratio of Amrutanjan Health Care Ltd changed from 37 on March 2019 to 42.2 on March 2023 . This represents a CAGR of 2.66% over 5 years. a1#The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 751.75 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 35.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Amrutanjan Health Care Ltd changed from ₹ 908.34 crore on March 2019 to ₹ 1680 crore on March 2023 . This represents a CAGR of 13.10% over 5 years. a1#The Revenue of Amrutanjan Health Care Ltd changed from ₹ 73.97 crore to ₹ 132.01 crore over 8 quarters. This represents a CAGR of 33.59% a1#The EBITDA of Amrutanjan Health Care Ltd changed from ₹ 6.34 crore to ₹ 21.19 crore over 8 quarters. This represents a CAGR of 82.82% a1#The Net Pr of Amrutanjan Health Care Ltd changed from ₹ 3.66 crore to ₹ 13.66 crore over 8 quarters. This represents a CAGR of 93.19% a1#The Dividend Payout of Amrutanjan Health Care Ltd changed from 26.32 % on March 2019 to 33.72 % on March 2023 . This represents a CAGR of 5.08% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Amrutanjan Health Care Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Amrutanjan Health Care Ltd

Period
Mar '1937
Mar '2038.5
Mar '2127.1
Mar '2234.5
Mar '2342.2

Company Fundamentals for Amrutanjan Health Care Ltd

Market Cap

2,173 Cr

EPS

15.6

P/E Ratio (TTM) *

48.3

P/B Ratio (TTM) *

7.5

Day’s High

771.0

Day’s Low

749.6

DTE *

0.0

ROE *

15.6

52 Week High

826.0

52 Week Low

556.05

ROCE *

21.4

* All values are consolidated

Last Updated time: 14 Jul 9.00 AM

* All values are consolidated

Last Updated time: 14 Jul 9.00 AM

Image

Amrutanjan Health Care Ltd

NSE: AMRUTANJAN

PRICE

751.75

-9.30 (-1.22%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Amrutanjan Health Care Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Amrutanjan Health Care Ltd

Market Value

2,173

Asset Value

260

7.3 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Amrutanjan Health Care Ltd482,173
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Amrutanjan Health Care Ltd

Earnings

44 Cr

48.3 X

PE Ratio

Market Cap

₹2173Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

44 Cr

48.3 X

PE Ratio

Market Cap

₹2173Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Amrutanjan Health Care Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Amrutanjan Health Care Ltd

Period
Mar '19908
Mar '20964
Mar '211661
Mar '222320
Mar '231681

* All values are a in crore

×

Historical Revenue of Amrutanjan Health Care Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Amrutanjan Health Care Ltd

Period
Jun '2274
Sep '22114
Dec '22101
Mar '23105
Jun '2382
Sep '23103
Dec '23121
Mar '24132

* All values are a in crore

×

Historical EBITDA of Amrutanjan Health Care Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Amrutanjan Health Care Ltd

Period
Jun '226
Sep '2219
Dec '2216
Mar '2318
Jun '2311
Sep '2311
Dec '2325
Mar '2421

* All values are a in crore

×

Historical Net Profit of Amrutanjan Health Care Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Amrutanjan Health Care Ltd

Period
Jun '224
Sep '2213
Dec '2211
Mar '2313
Jun '237
Sep '237
Dec '2317
Mar '2414

* All values are a in crore

×

Historical Dividend Payout of Amrutanjan Health Care Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Amrutanjan Health Care Ltd

Period
Mar '1926
Mar '2026
Mar '2120
Mar '2220
Mar '2334

* All values are a in %

About Amrutanjan Health Care Ltd

About Amrutanjan Health Care Ltd

    Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages & hygiene and services in pain management. Amrutanjan has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called 'Cold Snap Gel' and also a mint called 'tingle'. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%. Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company. 'Diakyur' for the treatment of Diabetes was introduced during 2000-2001. The name of Company changed from 'Amrutanjan Limited' to 'Amrutanjan Health Care Limited' during the year 2007-08. During the year 2009-10, the name of the Fine Chemicals Division of the Company was changed to Pharmaessense Chemistry Services Division. During April 2011 a new division under the name Amrutanjan Pain Management Center also known as CARE Specialized Pain Management Center was launched in Chennai. The Pharmaessense Chemistry Services Division was transferred to a wholly owned Subsidiary Company viz., Amrutanjan Pharmaessense Private Limited with all its assets and liabilities, excluding land during May 2011. Siva's Soft Drink Private Limited was acquired during February 2011 by way of transfer of shares. The Company launched Amrutanjan Headache Faster Relaxation Roll-on 10ml SKU; launched Amrutanjan Faster Relaxation Balm(white) during the year 2014-15. In FY 2016-17, the Subsidiary Company, Amrutanjan Pharmaessense Private Limited (Transferor Company) got merged with the Holding Company (M/s. Amrutanjan Health Care Limited/ Transferee Company), through Scheme of Amalgamation, effective from 1st July 2016. Accordingly, the assets and liabilities of Amrutanjan Pharmaessense Pvt Ltd as at 01st July, 2016 was taken over by the Company. Amrutanjan Comfy Snug Fit Sanitary napkin was launched in 2016-17. Comfy Snug Fit was launched in 2016. The New Maha Strong Pain Balm was re-launched in 2016. Orange variant was launched in addition to existing Apple variant during financial year 2018-19. The flavour Alphonso, the King of Mangoes', was launched in 200 ml Ready- to- drink recyclable PET format. Two more new variants, Comfy XLand Comfy Ultra were launched during 2019-20. The Company re-launched its headache Pain balm in 2021-22. It introduced Amrutanjan Comfy Sung Fit Regular Cottony in FY22. A new product, 'Amrutanjan Stop Pain Dental Gel' was launched for Oral Health Care.

Amrutanjan Health Care Ltd News Hub

News

Board of Amrutanjan Health Care recommends final dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting...

Read more

24 May 202409:25

News

Amrutanjan Health Care to conduct board meeting

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

15 May 202414:23

News

Board of Amrutanjan Health Care recommends second interim dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting...

Read more

10 Feb 202410:09

News

Amrutanjan Health Care to declare Quarterly Result

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 9 F...

Read more

02 Feb 202415:31

News

Board of Amrutanjan Health Care recommends First Interim Dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting...

Read more

11 Nov 202310:17

News

Amrutanjan Health Care to announce Quarterly Result

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

06 Nov 202311:10

Product Composition by Percentage (Revenue)

FAQs for PE of Amrutanjan Health Care Ltd

What is Amrutanjan Health Care Ltd current share price?

The current market price of Amrutanjan Health Care Ltd as of July 14, 2024 is ₹751.75.

What is Amrutanjan Health Care Ltd's market cap?

Amrutanjan Health Care Ltd's market capitalisation stood at ₹2,173 Cr as of July 14, 2024

What are Amrutanjan Health Care Ltd's total net assets?

According to Amrutanjan Health Care Ltd's most recent financial filings, the company's net assets total ₹260.4 Cr.

Is Amrutanjan Health Care Ltd making a profit or loss?

Amrutanjan Health Care Ltd's net Profit as of July 14, 2024 is close to ₹44 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199